Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-01-03 @ 4:19 AM
Study NCT ID:
NCT06135194
Status:
UNKNOWN
Last Update Posted:
2023-11-18
First Post:
2023-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib
Sponsor:
Beijing 302 Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DS8021-Brain metastases
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None